Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 龙虾 (Lobster) 龙虾 (Lobster) +29.60%
#3 MetaDAO MetaDAO +29.20%
#4 Rain Rain +25.00%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +20.66%
#6 Bedrock Bedrock +19.60%
#7 Pons Pons +17.61%
#8 Prom Prom +16.34%
#9 Ontology Gas Ontology Gas +14.70%
#10 Humanity Humanity +14.00%
Coin of the day
QuantixAI QuantixAI
Settings
Language
ENGLISH
Currency
USD
Theme
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Rank in Stocks #2605
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Share Price
$27.75
Market Cap
$7.84B
Change (1 day)
6.21%
Change (1 year)
-27.88%
Country
US
Trade Caris Life Sciences, Inc. (CAI)

Category

Healthcare
P/B ratio for Caris Life Sciences, Inc. (CAI)
P/B ratio as of 2026 TTM: 0
According to Caris Life Sciences, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Caris Life Sciences, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH